Please wait while the formulary information is being retrieved.
OPTIRAY 300 (IOVERSOL)
- Angiocardiography
- Angiography
- Aortography
- Arteriography
- Cardiac ventriculography
- CT scan of brain
- Peripheral arteriography
- Urography
- Venography
mg iodine/mL intravenous syringe
- Dosage information is not available
mg iodine/mL intravenous solution
- Dosage information is not available
- Actoplus Met
- Actoplus Met Xr
- alogliptin-metformin
- Fortamet
- glipizide-metformin
- Glucophage
- Glucophage Xr
- Glucovance
- Glumetza
- glyburide-metformin
- Janumet
- Janumet Xr
- Jentadueto
- Kazano
- Kombiglyze Xr
- linagliptin-metformin
- metformin
- pioglitazone-metformin
- Prandimet
- repaglinide-metformin
- Riomet
- saxagliptin-metformin
- sitagliptin-metformin
Contraindicated
- Methotrexate (anti-rheumatic)
- methotrexate sodium
- methotrexate sodium (PF)
- Rheumatrex
- Trexall
Severe
Moderate
- None
- None
Contraindicated
- Anuria
- Dehydration
- Hyperthyroidism
- Kidney disease with reduction in GFR
- Pheochromocytoma
- Seizure disorder
- Sickle cell disease
- Thyrotoxicosis
Severe
Moderate
- Asthma
- Hypertension
- Hypothyroidism
OPTIRAY 300 (IOVERSOL)
- Angiocardiography
- Angiography
- Aortography
- Arteriography
- Cardiac ventriculography
- CT scan of brain
- Peripheral arteriography
- Urography
- Venography
- None
- Nausea
More Frequent
Severe
Less Severe
- None
- None
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Acidosis
- Acute cerebral infarction
- Acute generalized exanthematous pustulosis
- Acute myocardial infarction
- Acute renal failure
- Anaphylaxis
- Angina
- Angioedema
- Anuria
- Bradycardia
- Bronchospastic pulmonary disease
- Cardiac arrest
- Cardiac arrhythmia
- DRESS syndrome
- Dyspnea
- Erythema multiforme
- Extravasation injury
- Hypertension
- Hypotension
- Hypothyroidism
- Hypoxia
- Laryngeal edema
- Pulmonary edema
- Seizure disorder
- Skin rash
- ST segment changes
- Stevens-johnson syndrome
- Thromboembolic disorder
- Toxic epidermal necrolysis
- Urticaria
Less Severe
- Acute abdominal pain
- Acute confusion
- Aphasia
- Back pain
- Blurred vision
- Bruising
- Chest pain
- Chills
- Conjunctivitis
- Cough
- Dizziness
- Dysgeusia
- Dysphagia
- Erythema
- Fatigue
- Fever
- Flushing
- General weakness
- Hallucinations
- Headache disorder
- Hematoma
- Hyperhidrosis
- Induration of skin
- Injection site sequelae
- Malaise
- Muscle spasm
- Muscle weakness
- Nasal congestion
- Pain
- Palpitations
- Paresthesia
- Periorbital edema
- Polyuria
- Pruritus of skin
- Rhinitis
- Skin swelling
- Sneezing
- Symptoms of anxiety
- Tinnitus
- Transient blindness
- Tremor
- Urinary retention
- Vasodilation of blood vessels
- Vertigo
- Visual changes
- Vomiting
- Xerostomia
Contraindicated
None
Severe Precaution
Ioversol
Reports of hypothyroidism, LV pressure changes. No safety and efficacy in neonates. Increased risk of adverse event with underlying asthma, hyper allergenic, congestive heart failure, serum creatinine > 1.5 mg/dL.
- 1 Day – 18 Years
- Reports of hypothyroidism, LV pressure changes. No safety and efficacy in neonates. Increased risk of adverse event with underlying asthma, hyper allergenic, congestive heart failure, serum creatinine > 1.5 mg/dL.
Management or Monitoring Precaution
None
Ioversol
- Severity Level:
2
- Additional Notes: Consider maternal diagnostic benefit versus potential fetal adverse effects
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Ioversol
Systemic absorption and excretion unknown. many contrast agents are excreted
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Systemic absorption and excretion unknown. many contrast agents are excreted |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
Ioversol
Renal-Elderly are more sensitive to adverse effects. Recommend adequate hydration before and after drug administration to decrease risk for contrast induced acute kidney injury.
| Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
| Increased Risk / Adverse Effects | Y | N | Y | N | N | Y |
BEERS: N HEDIS: N STOPP: N
No Known Risk
None
- None
Formulary Reference Tool